Home › Funds › PSP Research LLC › PHVS

PSP Research LLC position in PHVS

Havas NV · Health Care

PSP Research LLC reported holding 15,000 shares of PHVS (Havas NV) in its Q2 2026 13F filing — a position valued at US$519K, representing 0.28% of its reported portfolio and ranking #15 among its reported holdings. PSP Research LLC has disclosed PHVS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)15.00K sh
Reported value held$518.70K
Portfolio Weight0.28%
First reportedQ4 2025
Last changeNew

How PSP Research LLC's PHVS position evolved

PSP Research LLC first disclosed a stake in PHVS in Q4 2025 at 20,511 shares (US$569K). Across 3 filings, PSP Research LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 15,000 shares valued at US$519K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 20.51K $569.18K New
Q1 2026 20.00K $565.00K Reduce
Q2 2026 15.00K $518.70K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PHVS and 13F data

PHVS (Havas NV) is a Health Care company. 50 other funds we track also report a position in PHVS — the largest reported positions include GENERAL ATLANTIC, L.P. (US$226.5M), Foresite Capital Management IV, LLC (US$165.2M), venBio Partners LLC (US$160.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PHVS

All PHVS fund holders →